• Return to Headlines

Array Biopharma Falling Today on Above-Average Volume (ARRY)

By Amy Schwartz

The price of Array Biopharma shares has slipped to $9.37 (a 11.3% change) on heavy trading volume. About 2.8 million shares have been traded today, as compared to the 30-day average volume of 1.6 million shares. Spikes in volume can validate a breakout or signify a potential turning point.

SmarTrend recommended that subscribers consider buying shares of Array Biopharma on September 26th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $5.62. Since that recommendation, shares of Array Biopharma have risen 87.9%. We continue to monitor ARRY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Array Biopharma share prices have moved between a 52-week high of $13.40 and a 52-week low of $2.38 and are now trading 294% above that low price at $9.37 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.2% while the 200-day MA has slid 1.7%.

Keywords: unusual volume Array BioPharma

Ticker(s): ARRY